Atezolizumab and Recombinant Human Hyaluronidase/Lurbinectedin Regimen

**Semantic type:** Therapeutic or Preventive Procedure

**Definition:** A regimen consisting of atezolizumab and recombinant human hyaluronidase, and lurbinectedin that can be used in the treatment of extensive-stage small cell lung cancer (ES-SCLC).

**Synonyms:** - Atezolizumab and Hyaluronidase-tqjs/Lurbinectedin - Atezolizumab and Recombinant Human Hyaluronidase Plus Lurbinectedin - Atezolizumab and Recombinant Human Hyaluronidase-Lurbinectedin - Atezolizumab and Recombinant Human Hyaluronidase/Lurbinectedin - Lurbinectedin/Atezolizumab and Recombinant Human Hyaluronidase - Tecentriq Hybreza/Zepzelca